DIASAGE (DIABETIC)
SUGAPILL-M OD 500
Composition:
dapagliflozin-propanediol-monohydrate-10-mg-vildagliptin-100mg-metformin-hydrochloride-ip-500mg-sr
Indication:
help improve blood sugar control, along with a healthy diet and regular exercise.
DAPASUG-GM-10/500
Composition:
bilyared-tablets-dapagliflozin-propanediol-monohydrate-10-mg-glimepiride-ip-2mg-metformin-hydrochloride-ip-500mg-as-sustained-released
Indication:
Used for Type 2 Diabetes Mellitus to control blood sugar levels.
EMPASUG-SM 25/100/1000 TABS
Composition:
empagliflozin-25-mg-sitagliptin-100-mg-metformin-1000-sr
Indication:
High-strength triple therapy for better glycemic control in uncontrolled Type 2 diabetes.
EMPASUG-SM 10/100/1000 TABS
Composition:
empagliflozin-10-mg-sitagliptin-100-mg-metformin-1000-sr
Indication:
A triple-combination therapy for effective blood sugar control in Type 2 diabetes.
EmpaSug-SM-10-100-500sr
Composition:
empagliflozin-10mg-sitagliptin-100mg-metformin-hydrochloride-500mg
Indication:
It is used to manage type 2 diabetes mellitus by helping control blood sugar levels when diet and exercise alone are not enough.
EmpaSug-SM-25-100-500sr
.jpeg)
Composition:
empagliflozin-25mg-sitagliptin-100mg-metformin-hydrochloride-500mg
Indication:
It is used to manage type 2 diabetes mellitus by helping control blood sugar levels when diet and exercise alone are not enough.
SITANOW-M 100/1000 TABS
Composition:
sitagliptin-100mg-metformin-1000mg-sr
Indication:
for the management of type 2 diabetes mellitus in adults to improve glycemic control, especially when diet, exercise, and monotherapy are insufficient.
DAPASUG-M 5/500 TABS
Composition:
dapagliflozin-5mg-metformin-500mg-extended-release
Indication:
used to improve blood sugar control in adults with type 2 diabetes mellitus, especially when diet, exercise, and single-agent therapy do not provide adequate glycemic control.
VOGLISUG-GM-2/1000 TABS
Composition:
voglibose-0-2mg-glimepiride-2mg-metformin-hcl-1000
Indication:
for the treatment of type 2 diabetes mellitus in adults to achieve better blood sugar control, particularly in patients not adequately controlled with dual therapy.
SUGALIFE-S tab
.png)
Composition:
gliclazide-ip-60mg-as-sustained-release-form-sitagliptin-phosphate-monohydrate-ip-sitagliptin-100mg
Indication:
for the treatment of Type 2 Diabetes Mellitus in adults. It helps to control blood glucose levels by enhancing insulin secretion, reducing hepatic glucose production, and improving insulin sensitivity. Suitable when diet, exercise, and monotherapy are insufficient.
DAPASUG-VM-500 TABS
.png)
Composition:
dapagliflozin-propanediol-monohydrate-10-mg-vildagliptin-100mg-metformin-hydrochloride-ip-500mg-sr
Indication:
Used to manage type 2 diabetes mellitus in adults when blood sugar is not controlled with dual therapy. It helps lower blood glucose by improving insulin action, increasing insulin release, and promoting glucose loss through urine.
SITANOW-M 100/1000 TABS
.png)
Composition:
sitagliptin-100mg-metformin-1000mg-sr
Indication:
for the management of type 2 diabetes mellitus in adults to improve glycemic control, especially when diet, exercise, and monotherapy are insufficient.
VOGLISUG-GM-2/1000 TABS
.png)
Composition:
voglibose-0-2mg-glimepiride-2mg-metformin-hcl-1000
Indication:
for the treatment of type 2 diabetes mellitus in adults to achieve better blood sugar control, particularly in patients not adequately controlled with dual therapy.
VOGLISUG-GM-1/1000 TABS
Composition:
voglibose-0-1mg-glimepiride-1mg-metformin-hcl-1000
Indication:
Used for the treatment of type 2 diabetes mellitus when diet, exercise, or single-drug therapy are insufficient.
SUGALIFE-D 10/60
Composition:
dapagliflozin-10-mg-gliclazide-60-mg-sr
Indication:
Used for the management of Type 2 Diabetes Mellitus in adults to help control blood sugar levels. It combines Dapagliflozin (an SGLT2 inhibitor) and Gliclazide (a sulfonylurea) for improved glycemic control when diet, exercise, and monotherapy are not sufficient.
TRELALIFE-100
Composition:
trelagliptin-tablets-100-mg
Indication:
to improve blood sugar control in adults with type 2 diabetes mellitus, as monotherapy or in combination with other antidiabetic medicines when diet and exercise alone are not enough.
SUGAMIDE-M 0.5/500 TABS
Composition:
glimepiride-0-5mg-metformin-500mg-sr-nano-bi-layer-tablet-with-breakline
Indication:
Used for the treatment of type 2 diabetes mellitus in adults to improve blood sugar control when diet, exercise, and single drug therapy are not sufficient. Combines Glimepiride (stimulates insulin release) with Metformin SR (improves insulin sensitivity) in a nano-bi layer tablet for sustained and effective glycemic control.
BISINTRA-DP
Composition:
bisoprolol-fumarate-ip-5mg-dapagliflozin-propanediol-monohydrate-10mg-excipient-q-s
Indication:
for the management of hypertension, angina, and chronic heart failure, helping to reduce cardiovascular mortality and hospitalizations.
Empasug 25mg
.png)
Composition:
empagliflozin-25-mg-ir
Indication:
Type 2 diabetes mellitus (T2DM) to improve blood sugar control, Heart failure to reduce cardiovascular death and hospitalization, Chronic kidney disease (CKD) to slow progression and lower CV risk.
Empasug 10mg
.png)
Composition:
empagliflozin-10-mg-ir
Indication:
Improves blood sugar control, Reduces cardiovascular death and hospitalization, Slows kidney disease progression and reduces heart risks
Empasug-M 500/12.5
.png)
Composition:
empagliflozin-12-5-mg-metformin-500-mg-ir
Indication:
Used in adults with type 2 diabetes mellitus (T2DM) to improve blood sugar control as an adjunct to diet and exercise. Combines SGLT2 inhibitor (Empagliflozin) and biguanide (Metformin) for dual action on glucose regulation. Not for type 1 diabetes or diabetic ketoacidosis.
Empasug ST 100/10
.png)
Composition:
empagliflozin-10-mg-sitagliptin-100-mg
Indication:
Used in adults with type 2 diabetes mellitus (T2DM) to improve blood sugar control as an adjunct to diet and exercise. Combines SGLT2 inhibitor (Empagliflozin) and DPP-4 inhibitor (Sitagliptin) for dual glucose-lowering action. Not for type 1 diabetes or diabetic ketoacidosis.
IMIGRAPE
Composition:
imeglimin-500-ir
Indication:
used to manage type 2 diabetes. It contains Imiglimin, a dual-action drug that works by improving insulin sensitivity and enhancing insulin secretion. This combination helps in regulating blood sugar levels, promoting better glucose control. It is generally prescribed when lifestyle changes and other diabetes medications are insufficient. It’s particularly beneficial for adults with type 2 diabetes to help manage their condition more effectively.
LOBESUG TABLETS
Composition:
lobeglitazone-0-5mg
Indication:
helps improve glycemic control in adults by increasing insulin sensitivity and enhancing glucose utilization in peripheral tissues. This medication is typically used as monotherapy or in combination with other antidiabetic agents, along with diet and exercise, to achieve optimal blood sugar control.
LINASUG-DM 500
 (1).png)
Composition:
lingaliptin-5mg-dapagliflozin-10mg-metformin-hcl-sr-500mg-1000mg
Indication:
Reduces the hepatic glucose uptake by 19%.
LINASUG-M 5/500 Tab
Composition:
linagliptin-5-mg-and-metformin-hydrochloride-sr-500-mg-tablets
Indication:
Indicated as an adjunct to diet & exercise to improve glycemic Control in Adults with Type 2 Diabetes Mellitus
VOGLISUG-RAPID TAB
Composition:
repaglinide-1mg-voglibose-0-3mg
Indication:
Helps control blood sugar levels by stimulating insulin release and slowing carbohydrate absorption, thereby reducing post-meal blood glucose spikes.
TENISUG-PM TABS
Composition:
teneligliptin-20mg-pioglitazone-15mg-metformin-500-mg-er
Indication:
Used for the treatment of type 2 diabetes
VOGLISUG-TRIO 0.3 Tablets
Composition:
gliclazide-80mg-metformin-hcl-500mg-voglibose-0-3mg
Indication:
Moderate to severe Type II Diabetes, Type II diabetes not adequately controlled by monotherapy
VOGLISUG-TRIO 0.2 TABS
Composition:
voglibose-ip-0-2mg-gliclazide-ip-80mg-metformin-hydrochloride-ip-500mg
Indication:
Moderate to severe Type II Diabetes, Type II diabetes not adequately controlled by monotherapy
DAPASUG-GM-2 Tablet
Composition:
dapagliflozin-10mg-glimepiride-ip-2mg-metformin-hydrochloride-ip-1000mg-as-extended-release-form
Indication:
Patients with T2D with eCVD or multiple CV risk factors, to reduce the risk of hospitalization for heart failure
VOGLISUG-GM 3
Composition:
voglibose-0-3mg-glimepiride-2mg-metformin-hci-500mg
Indication:
Lowers post-prandial blood glucose levels in type II diabetics, Prevents sudden surge of glucose after meals, Reduces progression of IGT* to Diabetes.
VOGLISUG-GM
Composition:
voglibose-0-2mg-glimepiride-2mg-metformin-hcl-500mg
Indication:
Lowers post-prandial blood glucose levels in type II diabetics, Prevents sudden surge of glucose after meals, Reduces progression of IGT* to Diabetes.
VOGLISUG-0.3
Composition:
voglibose-0-3mg-mouth-dissolving
Indication:
Lowers post-prandial blood glucose levels in type II diabetics, Prevents sudden surge of glucose after meals, Reduces progression of IGT* to Diabetes.
VOGLISUG-0.2
Composition:
voglibose-0-2mg-mouth-dissolving
Indication:
Lowers post-prandial blood glucose levels in type II diabetics, Prevents sudden surge of glucose after meals, Reduces progression of IGT* to Diabetes.
VIAMETA-500 SR
Composition:
metformin-hydrochloride-500-sr-form
Indication:
Obese patients where it normalizes body weight and blood sugar level, Monotherapy for Adults with Type-II diabetes where diet, weight reduction and exercise have failed to control blood sugar level
VIAMETA-1000 SR
Composition:
metformin-hydrochloride-1000mg-sr-form
Indication:
Obese patients where it normalizes body weight and blood sugar level, Monotherapy for Adults with Type-II diabetes where diet, weight reduction and exercise have failed to control blood sugar level
TENISUG-PG
Composition:
teneligliptin-20mg-pioglitazone-15-mg
Indication:
For adults with Uncontrolled Type 2 Diabetes.
TENISUG-M 500
Composition:
teneligliptin-20mg-metformin-hydrochloride-500mg-prolonged-release
Indication:
Stage 2 Hypertension, Hypertension associated with diabetes.
TENISUG-M 1000
Composition:
teneligliptin-20mg-metformin-hydrochloride-1000mg-prolonged-release
Indication:
Stage 2 Hypertension, Hypertension associated with diabetes.
TENISUG-20
Composition:
teneligliptin-20mg
Indication:
Stage 2 Hypertension, Hypertension associated with diabetes.
TENIFIX-20
Composition:
teneligliptin-20mg
Indication:
As a monotherapy adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus (T2DM).
SUGAVIA-M 500
Composition:
sitagliptin-50mg-metformin-hydrochloride-ip-500mg
Indication:
As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
SUGAVIA-50
Composition:
sitagliptin-50mg
Indication:
As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
SUGAVIA-100
Composition:
sitagliptin-100mg
Indication:
As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
SUGAPILL-PIO
Composition:
vildagliptin-50mg-pioglitazone-hci-15mg
Indication:
Type 2 Diabetes
SUGAPILL-M 850
Composition:
vildagliptin-50mg-metformin-850mg-film-coated
Indication:
Type-2 Diabetes
SUGAPILL-M 500
Composition:
vildagliptin-50mg-metformin-500mg-film-coated
Indication:
Type-2 Diabetes.
SUGAPILL-M 1000
Composition:
vildagliptin-50mg-metformin-1000mg-film-coated
Indication:
Type-2 Diabetes
SUGAPILL-50
Composition:
vildagliptin-50mg
Indication:
Type-2 Diabetes
SUGAMIDE-PM-2 NANO FAST Tabs
Composition:
glimepiride-2mg-pioglitazone-15mg-metformin-500mg-in-sr
Indication:
Complete Control over Uncontrolled Diabetes, IMICKRO Nano Technology gives Immediate and Patterned Release (IPR) drug profile
SUGAMIDE-PM-2
Composition:
glimepiride-2mg-pioglitazone-15mg-metformin-500mg-in-sr
Indication:
Type 2 Diabetes
SUGAMIDE-PM-1
.png)
Composition:
glimepiride-1mg-pioglitazone-15mg-metformin-500mg-in-sr
Indication:
Type 2 Diabetes
SUGAMIDE-M4 FORTE
Composition:
glimepiride-4mg-metformin-1000mg
Indication:
Type 2 Diabetes
SUGAMIDE-M3 FORTE
Composition:
glimepiride-3mg-metformin-1000mg
Indication:
Type 2 Diabetes
SUGAMIDE-M2 1000
Composition:
glimepiride-2mg-metformin-1000mg-in-sr
Indication:
Metformin and glimepiride simultaneously targets insulin resistance and insulin deficiency in type 2 diabetes
SUGAMIDE-M2
Composition:
glimepiride-2mg-metformin-500mg-in-sr
Indication:
Metformin and glimepiride simultaneously targets insulin resistance and insulin deficiency in type 2 diabetes
SUGAMIDE-M1 1000
Composition:
glimepiride-1mg-metformin-1000mg-in-sr
Indication:
SUGAMIDE-M-2 NANO FAST Tabs
Composition:
glimepiride-2mg-metformin-500mg-in-sr
Indication:
Complete Control over Uncontrolled Diabetes, IMICKRO Nano Technology gives Immediate and Patterned Release (IPR) drug profile
SUGAMIDE-M-1
.png)
Composition:
glimepiride-1mg-metformin-500mg-bi-layer-tablet-in-sr
Indication:
Metformin and glimepiride simultaneously targets insulin resistance and insulin deficiency in type 2 diabetes
SUGAMIDE-2
Composition:
glimepiride-2mg
Indication:
Metformin and glimepiride simultaneously targets insulin resistance and insulin deficiency in type 2 diabetes
SUGALIFE-M
Composition:
gliclazide-80mg-metformin-500mg
Indication:
Obese Type 2 Diabets , Secondary falure with su/Metformin, Moderate fo severe NIDDm, NiDDm with vascular complications
SUGALIFE-40
Composition:
gliclazide-40mg
Indication:
Obese Type 2 Diabets , Secondary falure with su/Metformin, Moderate fo severe NIDDm, NiDDm with vascular complications
SITANOW-PM TABLETS
Composition:
sitagliptin-100-mg-pioglitazone-hydrochloride-ip-15-mg-metformin-hydrochloride-ip-500-mg-as-sustained-release-form
Indication:
For Type-II Diabetic Mellitus, Increases insulin secretion, Improves B-cell function, Low risk of hypoglycemia
SITANOW-M 500
Composition:
sitagliptin-50mg-metformin-hydrochloride-ip-500mg
Indication:
As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
SITANOW-M 1000
Composition:
sitagliptin-50mg-metformin-hydrochloride-ip-1000mg
Indication:
As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
SITANOW-50
Composition:
sitagliptin-50mg
Indication:
As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
SITANOW-100
Composition:
sitagliptin-100mg
Indication:
As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
LINASUG-M 2.5/500
Composition:
linagliptin-2-5-mg-metformin-hydrochloride-ip-500-mg
Indication:
used along with diet and exercise and sometimes with other medications to lower blood sugar levels in patients with type 2 diabetes
LINASUG-DP Tablet
Composition:
linagliptin-5mg-dapagliflozin-10mg
Indication:
Used medications for the treatment of type-2 diabetes mellitus (T2DM)
LINASUG-5
Composition:
linagliptin-5-mg
Indication:
used along with diet and exercise and sometimes with other medications to lower blood sugar levels in patients with type 2 diabetes
DAPASUG-VD-100
Composition:
dapagliflozin-10mg-vildagliptin-100mg-bilayered-in-sustained-release-tablet
Indication:
TYPE 2 DIABETES
DAPASUG-VD 50 (COMING SOON)
Composition:
dapagliflozin-10mg-vildagliptin-50mg
Indication:
Diffuse the load of Diabetes before it Blast
DAPASUG-VD 5/50 TABS
Composition:
dapagliflozin-5mg-vildagliptin-50mg
Indication:
TYPE 2 DIABETES
DAPASUG-TG 20
Composition:
dapagliflozin-10mg-teneligliptin-20mg
Indication:
Ensure Victory in controlling Diabetes
DAPASUG-ST-100
Composition:
sitagliptin-phosphate-monohydrate-100mg-dapagliflozin-propanediol-monohydrate-10mg
Indication:
A highly potent, reversible and selective sodium-glucose contransporter-2 inhibitor indicated worldwide for the treatment of Type 2 diabetes
DAPASUG-SM-500
Composition:
dapagliflozin-10mg-sitagliptin-100mg-metformin-er-500mg
Indication:
Treatment of Type 2 Diabetes mellitus
DAPASUG-SM 1000 TABLETS
Composition:
dapagliflozin-10mg-sitagliptin-100mg-metformin-hydrochloride-ip-1000mg-extended-release
Indication:
Treatment of Type 2 Diabetes mellitus
DAPASUG-M
Composition:
dapagliflozin-10mg-metformin-500mg-er
Indication:
Patients with heart failure with reduced ejection fraction, to reduce the risk of CV death and hospitalization for heart failure, Patients with T2D with eCVD or multiple CV risk factors, to reduce the risk of hospitalization for heart failure
DAPASUG-5
Composition:
dapagliflozin-5mg
Indication:
Type 2 Diabetes
DAPASUG-10
Composition:
dapagliflozin-10mg
Indication:
Type 2 Diabetes
ACARFIX-50
Composition:
acarbose-50mg
Indication:
A convenient and effective long-term option for the treatment of Type 2 Diabetes
ACARFIX-25
Composition:
acarbose-25mg
Indication:
A convenient and effective long-term option for the treatment of Type 2 Diabetes